Previous
Previous

PetVivo Holdings, Inc. Begins Process to Pursue Approval of Biomatrix Particulate Technology for Initial Human Indication

Next
Next

Dr. Thomas Yarbrough Joins PetVivo Holdings, Inc. as the Senior Research Director